Global Gastrointestinal (GI) Stents Market Size By Type (Biliary Stent, Esophageal Stent), By Application (Biliary Disease, Stomach Cancer), By Region, And Segment Forecasts, 2023 to 2032

The Global Gastrointestinal (GI) Stents Market was valued at USD 450 million in 2023 and is projected to surpass USD 780 million by 2031, growing at a CAGR of 7.1% during the forecast period of 2023-2031. The market is driven by the increasing prevalence of gastrointestinal diseases, advancements in stent technology, and a rising number of minimally invasive surgical procedures.

Gastrointestinal stents play a crucial role in treating conditions such as esophageal, biliary, and colorectal obstructions, primarily caused by malignancies or strictures. The growing geriatric population, which is more prone to GI disorders, along with rising awareness of non-invasive treatment options, is further fueling market growth.

Drivers

1. Rising Prevalence of Gastrointestinal Disorders

The increasing incidence of colorectal cancer, esophageal cancer, biliary diseases, and strictures is a key driver. With colorectal cancer being the third most diagnosed cancer globally, the demand for GI stents is expected to rise significantly.

2. Advancements in Stent Technology

Newer self-expanding metal stents (SEMS), bioresorbable stents, and drug-eluting stents are improving patient outcomes by offering better patency, flexibility, and reduced complications.

3. Increasing Adoption of Minimally Invasive Surgeries

The shift from traditional open surgeries to endoscopic and minimally invasive techniques is enhancing the use of GI stents, reducing hospital stays and post-operative complications.

Restraints

1. High Cost of Stents and Procedures

The cost of GI stents, particularly metallic and drug-eluting variants, remains high. This poses a challenge for patients in developing regions with limited healthcare reimbursement policies.

2. Risk of Stent Migration and Complications

Although stents significantly improve quality of life, stent migration, occlusion, perforation, and infections remain major concerns, limiting their adoption in some cases.

Opportunities

1. Growing Geriatric Population

With an aging global population, the prevalence of gastrointestinal malignancies and obstructions is increasing, driving the need for effective palliative and curative interventions like GI stents.

2. Expansion in Emerging Markets

Countries such as China, India, and Brazil are experiencing rising healthcare expenditure and better accessibility to advanced treatments, making them lucrative markets for GI stent manufacturers.

3. Development of Biodegradable and Smart Stents

Companies are investing in biodegradable and smart stents that adjust their shape or release drugs for enhanced treatment, opening new growth avenues.

Market by System Type Insights

Based on system type, the Self-Expanding Metal Stents (SEMS) segment dominated the market in 2023, accounting for the largest share. SEMS are widely preferred due to their longer patency rates, minimal complications, and effective relief in malignant obstructions.

The Self-Expanding Plastic Stents (SEPS) segment is expected to witness significant growth, particularly in cases requiring short-term stenting solutions, such as benign strictures.

Market by End-Use Insights

1. Hospitals Segment Leads

Hospitals remain the largest end-use segment, accounting for over 50% of the market share in 2023, due to the availability of advanced imaging and surgical techniques for stent placement.

2. Ambulatory Surgical Centers (ASCs) Growing Rapidly

The Ambulatory Surgical Centers (ASCs) segment is expected to witness the highest growth rate, driven by shorter recovery times, cost-effectiveness, and rising patient preference for outpatient procedures.

Market by Regional Insights

1. North America Holds the Largest Share

North America dominated the market in 2023, accounting for over 40% of the global revenue, owing to:

High prevalence of GI disorders

Strong healthcare infrastructure

Early adoption of advanced stenting technologies

2. Asia-Pacific to Witness the Fastest Growth

Asia-Pacific is projected to experience the highest CAGR during the forecast period, driven by:

Increasing healthcare expenditure

Rising patient awareness

Growing aging population prone to GI disorders in China, India, and Japan.

Competitive Scenario

The Global Gastrointestinal (GI) Stents Market is highly competitive, with key players focusing on product innovation, strategic collaborations, and geographical expansion.

Key Market Players:

Boston Scientific Corporation

Cook Medical

Medtronic plc

BD (Becton, Dickinson and Company)

Taewoong Medical

Olympus Corporation

Merit Medical Systems

Hobbs Medical, Inc.

Recent Developments:

2023: Boston Scientific launched a next-generation drug-eluting stent with improved patency for esophageal strictures.

2023: Medtronic partnered with a leading healthcare provider to expand access to GI stents in emerging markets.

2024: Cook Medical introduced biodegradable stents, reducing complications related to long-term stent placement.

Scope of Work – Global Gastrointestinal (GI) Stents Market

Report Metric Details

Market Size (2023) USD 450 million

Projected Market Size (2031) USD 780 million

CAGR (2023-2031) 7.1%

Key Segments by System Type SEMS, SEPS, Covered vs. Uncovered Stents

Key Segments by End-Use Hospitals, Ambulatory Surgical Centers

Leading Region North America

Key Players Boston Scientific, Cook Medical, Medtronic, BD, Olympus

FAQs

1. What is the current market size of the Global Gastrointestinal (GI) Stents Market?

The Global Gastrointestinal (GI) Stents Market was valued at USD 450 million in 2023 and is expected to grow at a CAGR of 7.1% to reach USD 780 million by 2031.

2. What is the major growth driver of the Global Gastrointestinal (GI) Stents Market?

The key growth driver is the rising prevalence of gastrointestinal diseases, coupled with technological advancements in stent materials and minimally invasive surgical techniques.

3. Which is the largest region during the forecast period in the Global Gastrointestinal (GI) Stents Market?

North America is the largest regional market, driven by high disease prevalence, strong healthcare infrastructure, and early adoption of innovative GI stents.

4. Which segment accounted for the largest market share in the Global Gastrointestinal (GI) Stents Market?

The Self-Expanding Metal Stents (SEMS) segment accounted for the largest market share in 2023, due to its high patency rate and effectiveness in malignant obstructions.

5. Who are the key market players in the Global Gastrointestinal (GI) Stents Market?

The major players include:

Boston Scientific Corporation

Cook Medical

Medtronic

BD (Becton, Dickinson and Company)

Taewoong Medical

Olympus Corporation

This report provides comprehensive insights into the Global Gastrointestinal (GI) Stents Market, covering market trends, key drivers, restraints, opportunities, competitive landscape, and regional analysis.